Search - tctmd.com

Displaying 101 - 120 of 836

Sort: Relevancy | Date

News Daily News

Everyone’s Glum About RECOVER IV: Where Shock Care Heads Next Is Unclear

Caitlin E. Cox

July 03, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for June 2024

Shelley Wood

July 02, 2024

News Daily News

RECOVER IV Impella Trial Halted in the Wake of DanGer Shock

Caitlin E. Cox

June 18, 2024

News Conference News SCAI 2024

AI Picks Up on Info Operators Miss on Angiograms: AI-ENCODE

L.A. McKeown

May 03, 2024

News Conference News SCAI 2024

CALORI: More Support for Eschewing Fasting Protocols Preprocedure

L.A. McKeown

May 02, 2024

News Features

After DanGer Shock’s Win in AMICS for Impella: What’s Next?

Caitlin E. Cox

May 02, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for April 2024

Shelley Wood

April 30, 2024

Presentation Fellows 2024

Case and Technique Reviews: High-Risk PCI and Cardiogenic Shock – The Role of Hemodynamic Support

Presenter: Sanjog Kalra

April 13, 2024

News Opinion Editor's Corner ACC 2024

What’s Going to Be Hot at ACC 2024

Shelley Wood

April 01, 2024

News Daily News

When Moving From DAPT to Monotherapy After PCI, the P2Y12 Inhibitor Matters

Yael L. Maxwell

March 21, 2024

Presentation THT 2024

Shock-Phenotype Matching Using Real-World Evidence: A New Paradigm for Prospective Enrollment in Clinical Trials of Acute MCS Devices in Cardiogenic Shock

Presenter: James W. Schurr

March 06, 2024

Presentation THT 2024

DPP3-Based Biotherapy in Cardiogenic Shock

Presenter: Mahir Karakas

March 06, 2024

Presentation THT 2024

Ivabridine in Cardiogenic Shock

Presenter: Maya Guglin

March 06, 2024

Presentation THT 2024

The Conundrum of Clinical Trials in Cardiogenic Shock

Presenter: JoAnn Lindenfeld

March 06, 2024

Presentation THT 2024

The RECOVER IV Study Overview

Presenter: Navin K. Kapur

March 05, 2024

Presentation THT 2024

Pulmonary Artery Catheter in Shock (PACCS)

Presenter: Shashank Shekhar Sinha

March 05, 2024

Presentation THT 2024

ECMO-Unload: Is This the Answer to ECLS-SHOCK?

Presenter: Dirk Westermann

March 05, 2024

Presentation THT Abstracts 2024

Outcomes of Impella 5.5 in Heart Failure-Related Cardiogenic Shock from the SURPASS (Surgical Unloading Renal Protection and Sustainable Support) Registry

Presenter: Jacob Abraham

March 05, 2024

Presentation THT Abstracts 2024

Clinical Outcomes and the Impact of SCAI Stage among ProtekDuo Right Ventricular Assist Device Recipients with Cardiogenic Shock: A Report from the Cardiogenic Shock Working Group

Presenter: Kevin John

March 05, 2024

Presentation THT Abstracts 2024

Clinical Outcomes and Adverse Events in Cardiogenic Shock Patients who Recieved Impella 5.0/5.5: A Report from the Cardiogenic Shock Working Group

Presenter: Justin Fried

March 05, 2024

Advertisement

Everyone’s Glum About RECOVER IV: Where Shock Care Heads Next Is Unclear

TCTMD’s Top 10 Most Popular Stories for June 2024

RECOVER IV Impella Trial Halted in the Wake of DanGer Shock

AI Picks Up on Info Operators Miss on Angiograms: AI-ENCODE

CALORI: More Support for Eschewing Fasting Protocols Preprocedure

After DanGer Shock’s Win in AMICS for Impella: What’s Next?

TCTMD’s Top 10 Most Popular Stories for April 2024

Case and Technique Reviews: High-Risk PCI and Cardiogenic Shock – The Role of Hemodynamic Support

What’s Going to Be Hot at ACC 2024

When Moving From DAPT to Monotherapy After PCI, the P2Y12 Inhibitor Matters

Shock-Phenotype Matching Using Real-World Evidence: A New Paradigm for Prospective Enrollment in Clinical Trials of Acute MCS Devices in Cardiogenic Shock

DPP3-Based Biotherapy in Cardiogenic Shock

Ivabridine in Cardiogenic Shock

The Conundrum of Clinical Trials in Cardiogenic Shock

The RECOVER IV Study Overview

Pulmonary Artery Catheter in Shock (PACCS)

ECMO-Unload: Is This the Answer to ECLS-SHOCK?

Outcomes of Impella 5.5 in Heart Failure-Related Cardiogenic Shock from the SURPASS (Surgical Unloading Renal Protection and Sustainable Support) Registry

Clinical Outcomes and the Impact of SCAI Stage among ProtekDuo Right Ventricular Assist Device Recipients with Cardiogenic Shock: A Report from the Cardiogenic Shock Working Group

Clinical Outcomes and Adverse Events in Cardiogenic Shock Patients who Recieved Impella 5.0/5.5: A Report from the Cardiogenic Shock Working Group

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content